Cargando…

Serum Level of Anti-Nucleocapsid, but Not Anti-Spike Antibody, Is Associated with Improvement of Long COVID Symptoms

Background: Long COVID is a condition characterized by long-term sequelae persisting after the typical convalescence period of COVID-19. Previous reports have suggested the role of an unsatisfactory immune response and impaired viral clearance in the pathogenesis of long COVID syndrome. We focused o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Varnai, Reka, Molnar, Tihamer, Zavori, Laszlo, Tőkés-Füzesi, Margit, Illes, Zsolt, Kanizsai, Andrea, Csecsei, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924883/ https://www.ncbi.nlm.nih.gov/pubmed/35214624 http://dx.doi.org/10.3390/vaccines10020165

Ejemplares similares

Severe Fatigue and Memory Impairment Are Associated with Lower Serum Level of Anti-SARS-CoV-2 Antibodies in Patients with Post-COVID Symptoms
por: Molnar, Tihamer, et al.
Publicado: (2021)

Fever after Vaccination against SARS-CoV-2 with mRNA-Based Vaccine Associated with Higher Antibody Levels during 6 Months Follow-Up
por: Kanizsai, Andrea, et al.
Publicado: (2022)

Adverse Reactions after Booster SARS-CoV-2 Vaccination Have Less Impact on Antibody Response than after Basic Vaccination Scheme
por: Kanizsai, Andrea, et al.
Publicado: (2023)

Cystatin-c May Indicate Subclinical Renal Involvement, While Orosomucoid Is Associated with Fatigue in Patients with Long-COVID Syndrome
por: Zavori, Laszlo, et al.
Publicado: (2023)

Acute Phase Protein Orosomucoid (Alpha-1-Acid Glycoprotein) Predicts Delayed Cerebral Ischemia and 3-Month Unfavorable Outcome after Aneurysmal Subarachnoid Hemorrhage
por: Zavori, Laszlo, et al.
Publicado: (2023)

Different Kinetics of Serum ADAMTS13, GDF-15, and Neutrophil Gelatinase-Associated Lipocalin in the Early Phase of Aneurysmal Subarachnoid Hemorrhage
por: Csecsei, Peter, et al.
Publicado: (2023)

Novel Predictors of Future Vascular Events in Post-stroke Patients—A Pilot Study
por: Schrick, Diana, et al.
Publicado: (2021)

Plasma Fibrinogen Independently Predicts Hypofibrinolysis in Severe COVID-19
por: Schrick, Diana, et al.
Publicado: (2021)

Serum Periostin May Help to Identify Patients with Poor Collaterals in the Hyperacute Phase of Ischemic Stroke
por: Spantler, Dora, et al.
Publicado: (2022)

A novel approach of platelet function test for prediction of attenuated response to clopidogrel
por: Ezer, Erzsebet, et al.
Publicado: (2019)

Role of microparticles derived from monocytes, endothelial cells and platelets in the exacerbation of COPD
por: Tőkés-Füzesi, Margit, et al.
Publicado: (2018)

Left atrial stiffness is superior to volume and strain parameters in predicting elevated NT-proBNP levels in systemic sclerosis patients
por: Porpáczy, Adél, et al.
Publicado: (2019)

Anti-spike, Anti-nucleocapsid and Neutralizing Antibodies in SARS-CoV-2 Inpatients and Asymptomatic Individuals
por: Brochot, Etienne, et al.
Publicado: (2020)

Galectin-3 and sST2: associations to the echocardiographic markers of the myocardial mechanics in systemic sclerosis – a pilot study
por: Vértes, Vivien, et al.
Publicado: (2022)

Longevity of anti-spike and anti-nucleocapsid antibodies after COVID-19 in solid organ transplant recipients compared to immunocompetent controls
por: Søfteland, John M., et al.
Publicado: (2022)

Screening for precapillary pulmonary hypertension in chronic myeloproliferative disorders: the role of N-terminal pro-B-type natriuretic peptide and vascular endothelial growth factor – a pilot study
por: Költő, Gyöngyvér, et al.
Publicado: (2020)

Detailed severity assessment of Cincinnati Prehospital Stroke Scale to detect large vessel occlusion in acute ischemic stroke
por: Tarkanyi, Gabor, et al.
Publicado: (2020)

Lower persistence of anti-nucleocapsid compared to anti-spike antibodies up to one year after SARS-CoV-2 infection
por: Van Elslande, Jan, et al.
Publicado: (2022)

SARS COV-2 anti-nucleocapsid and anti-spike antibodies in an emergency department healthcare worker cohort: September 2020 – April 2021
por: Wang, Ralph C., et al.
Publicado: (2022)

Detection of Anti-SARS-CoV-2 Nucleocapsid and Spike Antibodies in Patients with Coronavirus Disease 2019 in Japan
por: Furukawa, Hiroshi, et al.
Publicado: (2022)

Longitudinal clinico-serological analysis of anti-nucleocapsid and anti-receptor binding domain of spike protein antibodies against SARS-CoV-2
por: Deshpande, Gururaj Rao, et al.
Publicado: (2021)

Antibody detection of SARS-CoV spike and nucleocapsid protein
por: Chang, Mau-Sun, et al.
Publicado: (2004)

Assessment of platelet function in patients receiving tirofiban early after primary coronary intervention
por: Kupó, Péter, et al.
Publicado: (2016)

Circulating anti-SARS-CoV-2 nucleocapsid (N)-protein antibodies and anti-SARS-CoV-2 spike (S)-protein antibodies in an African setting: herd immunity, not there yet!
por: Mveang Nzoghe, Amandine, et al.
Publicado: (2021)

l-arginine, asymmetric and symmetric dimethylarginine for early outcome prediction in unselected cardiac arrest victims: a prospective cohort study
por: Csiszar, Beata, et al.
Publicado: (2021)

Spike-based COVID-19 immunization increases antibodies to nucleocapsid antigen
por: Dobaño, Carlota, et al.
Publicado: (2022)

Biomarker Associations in Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage
por: Spantler, Dora, et al.
Publicado: (2022)

Combination of rRT-PCR and Anti-Nucleocapsid/Anti-Spike Antibodies to Characterize Specimens with Very Low Viral SARs-CoV-2 Load: A Real-Life Experience
por: Florou, Zoe, et al.
Publicado: (2021)

Antibody Screening Results for Anti-Nucleocapsid Antibodies Toward the Development of a Lateral Flow Assay to Detect SARS-CoV-2 Nucleocapsid Protein
por: Cate, David M., et al.
Publicado: (2021)

Performance of Elecsys Anti-SARS CoV-2 (Roche) and VIDAS Anti-SARS CoV-2 (Biomérieux) for SARS-CoV-2 Nucleocapsid and Spike Protein Antibody Detection
por: Inés, Riberi María, et al.
Publicado: (2022)

Detection of SARS-CoV-2 Nucleocapsid, Spike, and Neutralizing Antibodies in Vaccinated Japanese
por: Midorikawa, Rie, et al.
Publicado: (2022)

Dynamic of humoral response to SARS-CoV-2 anti-Nucleocapsid and Spike proteins after CoronaVac vaccination
por: Bochnia-Bueno, Lucas, et al.
Publicado: (2022)

SARS-CoV-2 seroprevalence survey estimates are affected by anti-nucleocapsid antibody decline
por: Bolotin, Shelly, et al.
Publicado: (2021)

Detection of Anti-Nucleocapsid Antibody in COVID-19 Patients in Bangladesh Is not Correlated with Previous Dengue Infection
por: Lytton, Simon D., et al.
Publicado: (2021)

Anti-nucleocapsid antibody levels and pulmonary comorbid conditions are linked to post–COVID-19 syndrome
por: Jia, Xiaolin, et al.
Publicado: (2022)

General Anesthesia-Related Drop in Diastolic Blood Pressure May Impact the Long-Term Outcome in Stroke Patients Undergoing Thrombectomy
por: Abada, Alan, et al.
Publicado: (2022)

Low ficolin-3 levels in early follow-up serum samples are associated with the severity and unfavorable outcome of acute ischemic stroke
por: Füst, George, et al.
Publicado: (2011)

Performance of the Roche/Snibe electrochemiluminescent anti-SARS-COV-2 spike assays compared to the Roche/Abbott IgG nucleocapsid and Abbott IgM spike assays
por: Lau, C.S., et al.
Publicado: (2021)

On the Need to Determine the Contribution of Anti-Nucleocapsid Antibodies as Potential Contributors to COVID-19 Convalescent Plasma Efficacy
por: Focosi, Daniele, et al.
Publicado: (2022)

Anti-spike antibody response to the COVID vaccine in lymphoma patients
por: Della Pia, Alexandra, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_llc1c9to7j9ch01ou3rtan8kef